We didn’t invent the lab test,
We simply perfected it.
Back 
What is being tested in our cancer testing panels?
Click here to view a Sample Report related to this panel.
- Prostate Specific Antigen
- CA 19.9
Click here to view a Sample Report related to this panel.
- CA 15.3
- CA 19.9
- CA 125
Click here to view a Sample Report related to this panel.
- PSA, Free
- PSA, Total
- CA 19.9
- AFP (Alpha-Fetoprotein)
- HCG (Human Chronic Gonadotropin)
- CEA
Click here to view a Sample Report related to this panel.
- CA 15.3
- CA 19.9
- CA 125
- AFP (Alpha-Fetoprotein)
- HCG (Human Chronic Gonadotropin)
- CEA
What is a cancer panel ?
A cancer panel is a series of tests that measures cancer-related biomarkers in the blood. Alongside additional diagnostics, these panels are a critical component for cancer diagnosis and treatment. Blood testing is at the forefront of modern cancer research as a form of cancer screening for identifying and managing the disease in its early stages. Cancer blood testing is not limited to recognizing markers from blood cancers such as lymphoma and leukemia. These panels are multi-cancer early detection tests that can identify several types of cancer from all over the body.
Lab tests such as blood panels are effective for tracking cancer care with current patients. You may order a cancer blood test for a patient to examine the effectiveness of their cancer treatment and explore additional options.
- Recommendations for additional diagnostics
- Efficacy of current cancer treatment
- Presence of tumor-related antigens, proteins,and chemicals
What is measured in a cancer blood panel?
Since cancer panels screen for several types of cancer, they measure a diverse array of biomarkers. In particular, cancer blood tests search for tumor markers, a series of antigens, proteins, and chemicals produced by cancerous cells at a higher rate than regular cells.
Tumor Markers
Many tumor cells produce antigens. Different antigens have been identified, categorized, and connected to specific cancers, so antigen testing allows doctors to both detect and understand the nature of different cancer types. These antigens, some of which are labeled as cancer antigens (CA), are one of the central biomarkers measured in cancer blood tests.
At Access Medical Labs, our cancer blood tests measure for several cancer antigens, including CA 15.3, CA 19.9, and CA 125. Additional tumor markers include beta-human chorionic gonadotropin (beta HCG), and proteins, such as prostate-specific antigen (PSA), carcinoembryonic antigen (CEA), and alpha-fetoprotein (AFP). While many of these tumor markers are produced at a normal, healthy level, elevated levels indicate cancerous cells.
Which test do I need?
Access Medical Labs offers four different cancer blood panels:
The Male Basic Cancer Panel
Our Male Basic Cancer Panel tests for cancer antigen 19.9 and prostate-specific antigen (PSA). In elevated levels, CA 19.9 has been linked to pancreatic cancer. PSA, produced by both normal and malignant cells in the prostate gland, is a marker for prostate cancer. If your patient has a genetic history of these cancers or begins showing symptoms, this test provides a deeper look into blood biomarkers. Our Male Basic Cancer Panel tests for cancer antigen 19.9 and prostate-specific antigen (PSA). In elevated levels, CA 19.9 has been linked to pancreatic cancer. PSA, produced by both normal and malignant cells in the prostate gland, is a marker for prostate cancer. If your patient has a genetic history of these cancers or begins showing symptoms, this test provides a deeper look into blood biomarkers.
The Male Cancer Extended Panel
The Male Cancer Extended Panel measures additional cancer biomarkers. Along with CA 19.9, this test includes beta HCG, CEA, and AFP. Together, these markers test for many cancers, including liver, lung, thyroid, and colorectal cancer. Additionally, this panel measures PSA levels in greater detail. Total and free PSA are assessed to determine the blood's ratio of free PSA to bound PSA. Bound PSA levels are typically higher in cancerous conditions.
The Female Basic Cancer Panel
Our Female Basic Cancer Panel includes biomarkers for gynecologic cancers. Along with CA 19.9, correlated with pancreatic cancer, this panel includes CA 15.3, an epitope of glycoprotein MUC1 that is elevated in cancerous breast tissue, and CA 125, commonly linked to ovarian cancer. This test checks for signs of pancreatic cancer, breast cancer, or ovarian cancer.
The Male Cancer Extended Panel
This panel assesses tumor markers for pancreatic cancer, liver cancer, breast cancer, lung cancer, colorectal cancer, ovarian cancer, and thyroid cancer. By incorporating biomarkers AFP, CEA, and beta HCG with CAs 19.9, 15.3, and 125, this blood panel examines both gynecologic and general cancer markers.
All of our tests can be customized to fit your patient’s needs.
What is the testing process?
All blood samples must be collected at a doctor’s office, clinic, or hospital. Once your sample is received in our laboratory, our team of highly-trained lab technologists will analyze the sample and send the results to you and/or your healthcare provider within 24 hours.